Abstract
Background: Type 1 diabetes is one of the most common spreading diseases in Saudi Arabia. In addition, HbA1C is the gold standard measure for diabetes glycemic control, so the aim is to reduce the HbA1C to minimize the microvascular and macrovascular complications of diabetes. Aim: To measure the use of therapeutic insulin pumps for type 1 diabetic patients and asses the HbA1C level before and after the insulin pump insertion. Methods: A cross-sectional study was done to type 1 diabetic (T1D) on a Medtronic insulin pump with a sensor (basal vs. IQ) in KSH and a virtual clinic. Conclusion: Insulin pump therapy considers an ideal solution for the reduction in HbA1C, increased patients' treatment satisfaction, and maintaining glycemic control compared to injectable insulin.